Table 3.

The clinical demographics of MPH moderate responders and better responders

Variables	Moderate responder	Better responder	p-value
Gender, female/male (N)a	1/17	3/23	0.49
Age, years (mean±SD)b	11.44±1.68	11.38±1.83	0.91
BMI (mean	19.97±3.88	18.19±3.59	0.12
Daily dose (mg/day) (mean±SD)b	37.94±13.31	34.00±9.90	0.26

The differences in the gender distribution, age, BMI and MPH daily dose between MPH moderate responders and better responders were examined by independent t-test (b) or chi-square test (a). MPH: methylphenidate, BMI: body mass index, SD: standard deviation